Related Experiment Video
Updated: Jun 18, 2026

Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
Developing a genomic-based point-of-care diagnostic system for rheumatoid arthritis and multiple sclerosis
Fanis G Kalatzis1, Nikolaos Giannakeas, Themis P Exarchos
1Dept. of Material Science & Engineering, University of Ioannina, GR-45110, Ioannina, Greece. tkalatz@cc.uoi.gr
Abstract:
In this paper the methodology of designing a genomic-based point-of-care diagnostic system composed of a microfluidic Lab-On-Chip, algorithms for microarray image information extraction and knowledge modeling of clinico-genomic patient data is presented. The data are processed by genome wide association studies for two complex diseases: rheumatoid arthritis and multiple sclerosis. Respecting current technological limitations of autonomous molecular-based Lab-On-Chip systems the approach proposed in this work aims to enhance the diagnostic accuracy of the miniaturized LOC system. By providing a decision support system based on the data mining technologies, a robust portable integrated point-of-care diagnostic assay will be implemented. Initially, the gene discovery process is described followed by the detection of the most informative SNPs associated with the diseases. The clinical data and the selected associated SNPs are modeled using data mining techniques to allow the knowledge modeling framework to provide the diagnosis for new patients performing the point-of-care examination. The microfluidic LOC device supplies the diagnostic component of the platform with a set of SNPs associated with the diseases and the ruled-based decision support system combines this genomic information with the clinical data of the patient to outcome the final diagnostic result.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rapid Identification of Pathogens
Pharmacogenomics: Identification of New Drug Targets
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

